THIS AGREEMENT EFFECTIVE THE 1ST DAY OF NOVEMBER, 1999Royalty Assignment Agreement • April 5th, 2007 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
ROYALTY AND SUBLICENSE INCOME AGREEMENTRoyalty Assignment Agreement • October 27th, 2020 • PureTech Health PLC • Pharmaceutical preparations • Delaware
This ROYALTY ASSIGNMENT AGREEMENT (the “Agreement”), dated as of December 18, 2009, is by and among (i) PureTech Ventures, LLC, a Delaware limited liability company, (“PureTech”), (ii) Gelesis, Inc., a Delaware corporation, (“Gelesis-US”) and (iii) Gelesis LP (formerly AML-Dienstein B. V.), a Bermudan limited partnership (“Gelesis-Bermuda” and collectively with Gelesis-US, “Gelesis”).
ROYALTY ASSIGNMENT, CONFIRMATION, AMENDMENT, AND RESTATEMENT OF ROYALTY, AND AGREEMENTRoyalty Assignment Agreement • September 22nd, 2005 • Royal Gold Inc • Mineral royalty traders • Nevada
Royalty Assignment and AgreementRoyalty Assignment Agreement • September 22nd, 2005 • Royal Gold Inc • Mineral royalty traders • Colorado
This Royalty Assignment and Agreement (“Agreement”) is made effective as of December 26, 2002 (the “Effective Date”) by and between High Desert Mineral Resources, Inc., a Delaware corporation (“High Desert”) and High Desert Gold Corporation, a Nevada corporation (“HD Gold”).
MEMOGAIN ROYALTY ASSIGNMENT AGREEMENTRoyalty Assignment Agreement • August 4th, 2021
This Memogain Royalty Assignment Agreement (the ‘Assignment Agreement`) entered into effective as of January 1, 2016 (the "Effective Date")
MEMOGAIN ROYALTY ASSIGNMENT AGREEMENTRoyalty Assignment Agreement • April 30th, 2024 • Alpha Cognition Inc. • Biological products, (no disgnostic substances)
This Memogain Royalty Assignment Agreement (the ‘Assignment Agreement’) entered into effective as of January 1, 2016 (the “Effective Date”)
ROYALTY AND SUBLICENSE INCOME AGREEMENTRoyalty Assignment Agreement • October 5th, 2021 • Capstar Special Purpose Acquisition Corp. • Pharmaceutical preparations • Delaware
This ROYALTY ASSIGNMENT AGREEMENT (the “Agreement”), dated as of December 18, 2009, is by and among (i) PureTech Ventures, LLC, a Delaware limited liability company, (“PureTech”), (ii) Gelesis, Inc., a Delaware corporation, (“Gelesis-US”) and (iii) Gelesis LP (formerly AML-Dienstein B. V.), a Bermudan limited partnership (“Gelesis-Bermuda” and collectively with Gelesis-US, “Gelesis”).
